Search for products

Anti-Human IL-13 Azide Free

Product Specifications

Catalogue N°
855.140.000 - 200µg / 200µl
855.140.005 - 500µg / 500µl
Target species
Human
Specificity
Recognises both natural and recombinant human IL-13
Clone
B-B13
Application
ELISA
Flow Cytometry
Functional assay
Hybridoma
Myeloma X63/AG.8653 x Balb/c spleen cells
Immunisation
Recombinant human IL-13
Quantity
200µg or 500µg (Discovery Size also available please enquire)
Isotype
Mouse IgG1 Kappa light chain
Format
Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
Storage
Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
Biological Activity
Inhibits IL-13 induced proliferation on TF1 cell line
Anti-Human IL-13 Azide Free
Graph 1: TF1 cells proliferation measurement with resazurin after 4 days with IL-13 (6 ng/mL) and different concentrations of antibody
Anti-Human IL-13 Azide Free
Graph 2: CD4+ activated by PMA and ionomycine then marked with B-B13 on intracytoplasmic staining
Anti-Human IL-13 Azide Free
Graph 3: B-B13 with non-activated CD4+

BACKGROUND

IL-13 was first identified for its effects on B cells and monocytes, where it regulated class II expression, which triggered a changing IgE class, and prevented inflammatory cytokine production. It was also considered to be functionally redundant with IL-4. However, studies with conversion mice, neutralized antibodies and new reactors show that IL-13 has some unique functions that distinguish it from IL-4. Most gastrointestinal nematodes are resistant to intervention by type 2 cytokine responses, where IL-13 plays a leading role. By regulating exemption from cell intervention, IL-13 modifies intrallular organism resistance, including Leishmania major, Leishmania mexicana and Listeria monocytogenes. In the lungs, IL-13 is the central intermediary associated with allergic asthma, regulating eosinophilic inflammation, mucus secretion and sensitivity of airways. A particular cancer such as chronic lymphocytic leukemia B and Hodgkin's disease may involve the treatment of IL-13 efficiency function, where IL-13 modifies apoptosis or tumor cell growth. IL-13 can stay tumor surveillance. Accordingly, IL-13 inhibitors can be effective as anti-cancer anti-immunization by improving the anti-tumor type 1 protections. in scistosomiasis and asthma, indicating that it is the main controller of the effluent matrix. The mechanisms governing the production and / or function of IL-13, as well as IL-4, IL-12, IL-18, IFN-gamma, IL-10, TGF-beta, TNF-alpha and IL-4 were also studied. . The IL-13 receptor complex plays an important role. This review illustrates the efficiency functions of IL-13 and describes various ways of modifying its in vivo activity.

Version 11 - 05.21

For research use only

Documents

For any order, the purchaser acknowledges having read and accepted the terms and conditions described on the Diaclone website.

Formats Available

855.140.000 200µg / 200µl
855.140.005 500µg / 500µl

Ordering options

Place an order
by phone: +33 (0)3 81 41 38 38
or by email: info [at] diaclone [dot] com ( Subject: Diaclone's order, Body: Anti-Human IL-13 Azide Free 855.140.000 - 200µg / 200µl 855.140.005 - 500µg / 500µl )

Please contact us to discuss bulk orders